english.prescrire.org > Spotlight > "Spotlight"
"Spotlight"

In the October issue of Prescrire International - Dexrazoxane in children: European disagreements and arbitration

FREE DOWNLOAD In 2017, dexrazoxane was re-approved in the European Union for use in children treated with high doses of anthracyclines. However, uncertainties remain.
Full text available for free download.

Summary

  • Since its introduction onto the European market in the 1990s, evaluation of dexrazoxane is insufficient to determine its harm-benefit balance.
     
  • Nearly 20 years on, disagreement between agencies shows that substantial uncertainties remain.

Full text available for free download.

 ©Prescrire 1 October 2018

"Dexrazoxane in children: European disagreements and arbitration" Prescrire Int 2018; 27 (197): 245. (Pdf, free)

Share Share on Facebook Share on Twitter